Form 8-K - Current report:
SEC Accession No. 0001171520-21-000432
Filing Date
2021-11-02
Accepted
2021-11-02 16:42:42
Documents
14
Period of Report
2021-11-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 eps9887.htm   iXBRL 8-K 30995
2 FOR IMMEDIATE RELEASE ex99-1.htm EX-99.1 8624
3 GRAPHIC clearpoint-logo.jpg GRAPHIC 54914
  Complete submission text file 0001171520-21-000432.txt   294505

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE clpt-20211102.xsd EX-101.SCH 3046
5 XBRL LABEL FILE clpt-20211102_lab.xml EX-101.LAB 34224
6 XBRL PRESENTATION FILE clpt-20211102_pre.xml EX-101.PRE 22373
7 EXTRACTED XBRL INSTANCE DOCUMENT eps9887_htm.xml XML 3607
Mailing Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075
Business Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075 9499006833
ClearPoint Neuro, Inc. (Filer) CIK: 0001285550 (see all company filings)

EIN.: 582394628 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34822 | Film No.: 211372052
SIC: 3841 Surgical & Medical Instruments & Apparatus